Blockbuster Enhertu may get tumor agnostic label, targeting any HER2-expressing cancer: GlobalData Read more
Long road ahead for non-statin therapies in Australia dyslipidemia treatment space: GlobalData Read more
Tough market conditions fail to deter discussions about R&D investments, new technologies: GlobalData Read more
Novel pipeline therapies to drive diabetic neuropathic pain market across 7MM to $3 bn in 2031: GlobalData Read more
Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData Read more